Clinical and Immunological Insights on Severe, Adverse Neurotropic and Viscerotropic Disease following 17D Yellow Fever Vaccination
- 1 January 2010
- journal article
- case report
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 17 (1) , 118-126
- https://doi.org/10.1128/cvi.00369-09
Abstract
Yellow fever (YF) vaccines (17D-204 and 17DD) are well tolerated and cause very low rates of severe adverse events (YEL-SAE), such as serious allergic reactions, neurotropic adverse diseases (YEL-AND), and viscerotropic diseases (YEL-AVD). Viral and host factors have been postulated to explain the basis of YEL-SAE. However, the mechanisms underlying the occurrence of YEL-SAE remain unknown. The present report provides a detailed immunological analysis of a 23-year-old female patient. The patient developed a suspected case of severe YEL-AVD with encephalitis, as well as with pancreatitis and myositis, following receipt of a 17D-204 YF vaccination. The patient exhibited a decreased level of expression of Fc-γR in monocytes (CD16, CD32, and CD64), along with increased levels of NK T cells (an increased CD3 + CD16 +/− CD56 +/− /CD3 + ratio), activated T cells (CD4 + and CD8 + cells), and B lymphocytes. Enhanced levels of plasmatic cytokines (interleukin-6 [IL-6], IL-17, IL-4, IL-5, and IL-10) as well as an exacerbated ex vivo intracytoplasmic cytokine pattern, mainly observed within NK cells (gamma interferon positive [IFN-γ + ], tumor necrosis factor alpha positive [TNF-α + ], and IL-4 positive [IL-4 + ]), CD8 + T cells (IL-4 + and IL-5 + ), and B lymphocytes (TNF-α + , IL-4 + , and IL-10 + ). The analysis of CD4 + T cells revealed a complex profile that consisted of an increased frequency of IL-12 + and IFN-γ + cells and a decreased percentage of TNF-α + , IL-4 + , and IL-5 + cells. Depressed cytokine synthesis was observed in monocytes (TNF-α + ) following the provision of antigenic stimuli in vitro . These results support the hypothesis that a strong adaptive response and abnormalities in the innate immune system may be involved in the establishment of YEL-AND and YEL-AVD.Keywords
This publication has 23 references indexed in Scilit:
- Adverse event reports following yellow fever vaccinationVaccine, 2008
- Case of Yellow Fever Vaccine–Associated Viscerotropic Disease with Prolonged Viremia, Robust Adaptive Immune Responses, and Polymorphisms in CCR5 and RANTES GenesThe Journal of Infectious Diseases, 2008
- Immune Response during Adverse Events after 17D‐Derived Yellow Fever Vaccination in EuropeThe Journal of Infectious Diseases, 2008
- Yellow Fever–Associated Viscerotropic Disease in Barcelona, SpainJournal of Travel Medicine, 2008
- Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccinationVaccine, 2008
- Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?Clinical and Experimental Immunology, 2007
- Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-γ and interleukin-10 and low frequency of tumour necrosis factor-α+ monocytes are hallmarks of active human visceral Leishmaniasis due toLeishmania chagasiinfectionClinical and Experimental Immunology, 2006
- Characterization of a viscerotropic yellow fever vaccine variant from a patient in BrazilVaccine, 2006
- Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse eventsVaccine, 2005
- Hepatitis and death following vaccination with 17D-204 yellow fever vaccineThe Lancet, 2001